Cancervax, Corp.
Records under this name other than patents Cancervax, Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Cancervax, Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,070,939 | Methods for detecting vasculopathies and tumors Lapsed on the fee record Ended Jul 4, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 4, 2014 | From the USPTO record |
| US 6,491,926 | 35 kD tumor associated protein antigen: uses and methods of detection Term ended Term ended Apr 18, 2010 · From the USPTO record | Term ended | Term ended Apr 18, 2010 | From the USPTO record |
| US 7,097,846 | 35 KD Tumor Associated Protein Antigen: Uses and Methods of Detection Term ended Term ended Apr 18, 2010 · Medium confidence | Term ended | Term ended Apr 18, 2010 | Medium confidence |
| US 5,840,317 | Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen Term ended Term ended no later than Nov 24, 2018 · Low confidence | Term ended | Term ended no later than Nov 24, 2018 | Low confidence |
| US 5,882,654 | Polyvalent melanoma vaccine Term ended Term ended no later than Mar 16, 2019 · Low confidence | Term ended | Term ended no later than Mar 16, 2019 | Low confidence |
| US 5,993,828 | Tumor associated antigen compositions and methods Term ended Term ended no later than Nov 30, 2019 · Low confidence | Term ended | Term ended no later than Nov 30, 2019 | Low confidence |